Pharma News, 2023

Oramed Pharmaceuticals’ investigational oral drug ORMD-0801 did not meet the primary endpoint of improving glycemic control in a phase 3 clinical trial evaluating the drug in type 2 diabetes. ...

The FDA has approved updated labeling for Novo Nordisk’s Rybelsus (semaglutide) as a first-line treatment for adults with type 2 diabetes who have not previously been treated. ...

Researchers studying new methods for controlling blood sugar levels in type II diabetes have found,hat the old class of antipsychotic drugscan be used to treat hyperglycemia.  ...

Two top pharma companies have exited the UK’s voluntary medicines pricing agreement in protest at what the industry has said is a “punitive” system of revenue clawbacks, casting doubt on the ...

China’s Luye Pharma has claimed its first FDA approval, getting a green light for Rykindo, an injectable formulation of the antipsychotic risperidone given every two weeks. ...

Scientists from The Australian National University (ANU) and the Peter MacCallum Cancer Centre have discovered that a protein, called Menin, contributes to abnormal deactivation of specific genes i...

Sanofi Ventures – focused on early-to-mid stage investing, company co-creation, leading financing rounds, and prioritising those companies advancing innovation – has announced an additional mul...

Cure Parkinson’s is delighted to announce that following promising results reported at phase 2 in 2020, a large-scale phase 3 clinical trial of ambroxol, a drug currently in use to treat respiratory...

The US Food and Drug Administration (FDA) has approved AstraZeneca and Avillion’s Airsupra (albuterol/budesonide), to treat asthma.

Biocon already produces a biosimilar copycat of Sanofi's Lantus. But its submission for its knockoff of Novo Nordisk's NovoLog has been hit with an FDA complete response letter.  ...

The FDA has approved Sanofi Pasteur’s supplemental biologics license application (sBLA) for  its Adacel vaccine to provide immunization during the third trimester of pregnancy to prevent per...

The biopsy test is the first companion diagnostic approved for entrectinib for individuals who do not have an available tissue sample.